{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T05:12:20Z","timestamp":1791868340938,"version":"4.3.4"},"reference-count":113,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T00:00:00Z","timestamp":1743379200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T00:00:00Z","timestamp":1743379200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Therapeutic Advances in Endocrinology"],"published-print":{"date-parts":[[2025,10]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>The pathophysiology of polycystic ovary syndrome (PCOS) is complex and heterogeneous. This systematic review and meta-analysis aimed to determine the triglyceride\u2013glucose index and lipid ratios in women with and without PCOS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Literature searches were performed in PubMed, Scopus, Web of Science, Scielo, and Embase for studies reporting the triglyceride\u2013glucose index and total cholesterol\/high-density lipoprotein (HDL)-cholesterol, triglyceride\/HDL-cholesterol, and low-density lipoprotein (LDL)-cholesterol\/HDL-cholesterol ratios. Results are reported as standardized mean differences (SMDs) along with their 95% confidence intervals (CIs).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      The search identified 61 observational studies, including case\u2013control (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      \u2009=\u200937), cohort (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      \u2009=\u20092), and cross-sectional (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      \u2009=\u200922) studies reporting results of interest according to different PCOS diagnosis criteria. Compared with the control group, the PCOS group presented increased circulating triglyceride\u2013glucose index (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      \u2009=\u20099 studies, SMD, 0.41; 95% CI, 0.08\u20130.74) and total cholesterol\/HDL-cholesterol (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      \u2009=\u200935 studies, SMD, 1.70; 95% CI, 0.69\u20132.70), triglyceride\/HDL-cholesterol (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      \u2009=\u200931 studies; SMD, 0.81; 95% CI, 0.43\u20131.19), and LDL-cholesterol\/HDL-cholesterol (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      \u2009=\u200925 studies, SMD, 2.40; 95% CI, 0.45\u20134.35) ratios. Statistical heterogeneity values were very high (\n                      <jats:italic toggle=\"yes\">I<\/jats:italic>\n                      <jats:sup>2<\/jats:sup>\n                      \u2009&gt;\u200990%). The PCOS group displayed significantly higher body mass index and homeostatic model assessment of insulin resistance. The PCOS group was younger than the control group and had a higher total cholesterol\/HDL-cholesterol ratio, and other lipid variables were comparable in all groups.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Patients with PCOS show significantly higher triglyceride\u2013glucose index and total cholesterol\/HDL-cholesterol, triglyceride\/HDL-cholesterol, and LDL-cholesterol\/HDL-cholesterol ratios than those without the syndrome.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/20420188251328840","type":"journal-article","created":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T14:27:57Z","timestamp":1743431277000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":9,"title":["Triglyceride\u2013glucose index and lipid ratios in women with and without polycystic ovary syndrome: a systematic review and meta-analysis"],"prefix":"10.1177","volume":"16","author":[{"given":"Juan R.","family":"Ulloque-Badaracco","sequence":"first","affiliation":[{"name":"Facultad de Ciencias de la Salud, Universidad Peruana de Ciencias Aplicadas, Lima, Peru"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esteban A.","family":"Alarcon-Braga","sequence":"additional","affiliation":[{"name":"Facultad de Ciencias de la Salud, Universidad Peruana de Ciencias Aplicadas, Lima, Peru"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrique A.","family":"Hernandez-Bustamante","sequence":"additional","affiliation":[{"name":"Grupo Peruano de Investigaci\u00f3n Epidemiol\u00f3gica, Unidad para la Generaci\u00f3n y S\u00edntesis de Evidencias en Salud, Universidad San Ignacio de Loyola, Lima, Peru"},{"name":"Sociedad Cient\u00edfica de Estudiantes de Medicina de la Universidad Nacional de Trujillo, Trujillo, Peru"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan C.","family":"Cabrera-Guzm\u00e1n","sequence":"additional","affiliation":[{"name":"Facultad de Ciencias de la Salud, Universidad Peruana de Ciencias Aplicadas, Lima, Peru"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Dotto-Vasquez","sequence":"additional","affiliation":[{"name":"Facultad de Ciencias de la Salud, Universidad Peruana de Ciencias Aplicadas, Lima, Peru"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gian F.","family":"Maldonado-Basurto","sequence":"additional","affiliation":[{"name":"Facultad de Ciencias de la Salud, Universidad Peruana de Ciencias Aplicadas, Lima, Peru"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Germ\u00e1n","family":"Rivera-Cabrera","sequence":"additional","affiliation":[{"name":"Facultad de Ciencias de la Salud, Universidad Peruana de Ciencias Aplicadas, Lima, Peru"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherelym H.","family":"Maita-Arauco","sequence":"additional","affiliation":[{"name":"Facultad de Ciencias de la Salud, Universidad Peruana de Ciencias Aplicadas, Lima, Peru"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andres A.","family":"Horruitiner-Mendoza","sequence":"additional","affiliation":[{"name":"Facultad de Ciencias de la Salud, Universidad Peruana de Ciencias Aplicadas, Lima, Peru"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Percy","family":"Herrera-A\u00f1azco","sequence":"additional","affiliation":[{"name":"Facultad de Ciencias de la Salud, Universidad Privada del Norte, Trujillo, Peru"},{"name":"Red Peruana de Salud Colectiva, Lima, Peru"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9158-1108","authenticated-orcid":false,"given":"Vicente A.","family":"Benites-Zapata","sequence":"additional","affiliation":[{"name":"Unidad de Investigaci\u00f3n para la Generaci\u00f3n y S\u00edntesis de Evidencias en Salud, Universidad San Ignacio de Loyola, Avenida La Fontana #550 La Molina, Lima, Peru"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2801-416X","authenticated-orcid":false,"given":"Faustino R.","family":"P\u00e9rez-L\u00f3pez","sequence":"additional","affiliation":[{"name":"Instituto Aragon\u00e9s de Ciencias de la Salud, Facultad de Medicina, Universidad de Zaragoza, Zaragoza, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2025,3,31]]},"reference":[{"key":"e_1_3_4_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.csbj.2020.06.023"},{"key":"e_1_3_4_3_2","doi-asserted-by":"publisher","DOI":"10.23736\/S0026-4784.19.04404-6"},{"key":"e_1_3_4_4_2","article-title":"Global burden and epidemiological prediction of polycystic ovary syndrome from 1990 to 2019: a systematic analysis from the Global Burden of Disease Study 2019","volume":"19","author":"Zhang J","year":"2024","unstructured":"Zhang J, Zhu Y, Wang J, et al. Global burden and epidemiological prediction of polycystic ovary syndrome from 1990 to 2019: a systematic analysis from the Global Burden of Disease Study 2019. PLoS One 2024; 19: e0306991.","journal-title":"PLoS One"},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.1080\/09513590.2024.2359031"},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.1007\/s43032-021-00516-3"},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12958-016-0203-8"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2017.09.016"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/cen.13477"},{"key":"e_1_3_4_10_2","article-title":"Association between insulin resistance indices and liver function parameters among women with polycystic ovary syndrome","volume":"7","author":"Saei Ghare Naz M","year":"2024","unstructured":"Saei Ghare Naz M, Mousavi M, Firouzi F, et al. Association between insulin resistance indices and liver function parameters among women with polycystic ovary syndrome. Endocrinol Diabetes Metab 2024; 7: e490.","journal-title":"Endocrinol Diabetes Metab"},{"key":"e_1_3_4_11_2","first-page":"94","article-title":"Body composition, glucose metabolism markers and serum androgens\u2014association in women with polycystic ovary syndrome","volume":"64","author":"Kozakowski J","year":"2013","unstructured":"Kozakowski J, Zgliczy\u0144ski W. Body composition, glucose metabolism markers and serum androgens\u2014association in women with polycystic ovary syndrome. Endokrynol Pol 2013; 64: 94\u2013100.","journal-title":"Endokrynol Pol"},{"key":"e_1_3_4_12_2","article-title":"Homocysteine, vitamin B12, and folate circulating levels in women with and without polycystic ovary syndrome: a systematic review and meta-analysis","volume":"20","author":"Ulloque-Badaracco JR","year":"2024","unstructured":"Ulloque-Badaracco JR, Al-Kassab-C\u00f3rdova A, Hern\u00e1ndez-Bustamante EA, et al. Homocysteine, vitamin B12, and folate circulating levels in women with and without polycystic ovary syndrome: a systematic review and meta-analysis. Womens Health (Lond) 2024; 20: 17455057241279039.","journal-title":"Womens Health (Lond)"},{"key":"e_1_3_4_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2020.154193"},{"key":"e_1_3_4_14_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12944-023-01860-w"},{"key":"e_1_3_4_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/aogs.14863"},{"key":"e_1_3_4_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2010.12.027"},{"key":"e_1_3_4_17_2","doi-asserted-by":"publisher","DOI":"10.1080\/01443615.2017.1318840"},{"key":"e_1_3_4_18_2","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0214-9168(10)70005-X","article-title":"Cocientes lipoproteicos: significado fisiol\u00f3gico y utilidad cl\u00ednica de los \u00edndices aterog\u00e9nicos en prevenci\u00f3n cardiovascular","volume":"22","author":"Mill\u00e1n J","year":"2010","unstructured":"Mill\u00e1n J, Pint\u00f3 X, Mu\u00f1oz A, et al. Cocientes lipoproteicos: significado fisiol\u00f3gico y utilidad cl\u00ednica de los \u00edndices aterog\u00e9nicos en prevenci\u00f3n cardiovascular. Cl\u00edn Investig Arterioscler 2010; 22: 25\u201332.","journal-title":"Cl\u00edn Investig Arterioscler"},{"key":"e_1_3_4_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.dsx.2018.03.014"},{"key":"e_1_3_4_20_2","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page MJ","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 2021; 372: n71.","journal-title":"BMJ"},{"key":"e_1_3_4_21_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13643-016-0384-4"},{"key":"e_1_3_4_22_2","doi-asserted-by":"publisher","DOI":"10.1037\/h0031619"},{"key":"e_1_3_4_23_2","doi-asserted-by":"publisher","DOI":"10.2307\/2529310"},{"key":"e_1_3_4_24_2","doi-asserted-by":"publisher","DOI":"10.1177\/20503121241253957"},{"key":"e_1_3_4_25_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.315.7109.629"},{"key":"e_1_3_4_26_2","first-page":"89","article-title":"A nonparametric \u201cTrim and Fill\u201d method of accounting for publication bias in meta-analysis","volume":"95","author":"Duval S","year":"2000","unstructured":"Duval S, Tweedie R. A nonparametric \u201cTrim and Fill\u201d method of accounting for publication bias in meta-analysis. J Am Stat Assoc 2000; 95: 89\u201398.","journal-title":"J Am Stat Assoc"},{"key":"e_1_3_4_27_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-5-13"},{"key":"e_1_3_4_28_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.331.7521.903"},{"key":"e_1_3_4_29_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12874-022-01779-3"},{"key":"e_1_3_4_30_2","doi-asserted-by":"publisher","DOI":"10.1002\/jrsm.1356"},{"key":"e_1_3_4_31_2","first-page":"23","article-title":"Lipid accumulation product (LAP) and visceral adiposity index (VAI) as markers of insulin resistance and metabolic associated disturbances in young argentine women with polycystic ovary syndrome","volume":"49","author":"Abruzzese GA","year":"2017","unstructured":"Abruzzese GA, Cerrrone GE, Gamez JM, et al. Lipid accumulation product (LAP) and visceral adiposity index (VAI) as markers of insulin resistance and metabolic associated disturbances in young argentine women with polycystic ovary syndrome. Horm Metab Res 2017; 49: 23\u201329.","journal-title":"Horm Metab Res"},{"key":"e_1_3_4_32_2","first-page":"39","article-title":"Dyslipidemia and oxidative stress in Iraqi women with poly cystic ovary syndroms","volume":"4","author":"Ahmed Alobaidi AH","year":"2015","unstructured":"Ahmed Alobaidi AH, Khalil Abrahem M, Shahab Ahmad S, et al. Dyslipidemia and oxidative stress in Iraqi women with poly cystic ovary syndroms. World J Pharm Pharm Sci 2015; 4: 39\u201348.","journal-title":"World J Pharm Pharm Sci"},{"key":"e_1_3_4_33_2","first-page":"299","article-title":"Anti-M\u00fcllerian hormone in polycystic ovary syndrome subgroups","volume":"131","author":"A-Hakeim H","year":"2015","unstructured":"A-Hakeim H, Jebur I, Hassoon S. Anti-M\u00fcllerian hormone in polycystic ovary syndrome subgroups. Eur J Sci Res 2015; 131: 299\u2013309.","journal-title":"Eur J Sci Res"},{"key":"e_1_3_4_34_2","first-page":"8","article-title":"Roles of C-peptide and triglyceride as effective indices for insulin resistance investigations in Iraqi women with polycystic ovarian syndrome","author":"Al-Murshedi HH","year":"2022","unstructured":"Al-Murshedi HH, Al-Tu\u2019ma FJ, Hadi EA, et al. Roles of C-peptide and triglyceride as effective indices for insulin resistance investigations in Iraqi women with polycystic ovarian syndrome. J Contemp Med Sci 2022; 8.","journal-title":"J Contemp Med Sci"},{"key":"e_1_3_4_35_2","first-page":"77","article-title":"Evaluate relationship between insulin resistance and serum lipoprotein ratio in polycystic ovarian syndrome","volume":"6","author":"Ambiger S.","year":"2016","unstructured":"Ambiger S. Evaluate relationship between insulin resistance and serum lipoprotein ratio in polycystic ovarian syndrome. Int J Sci Res Pub 2016; 6: 77\u201383.","journal-title":"Int J Sci Res Pub"},{"key":"e_1_3_4_36_2","doi-asserted-by":"publisher","DOI":"10.21856\/j-PEP.2017.3.01"},{"key":"e_1_3_4_37_2","doi-asserted-by":"publisher","DOI":"10.17582\/journal.pjz\/20221024151005"},{"key":"e_1_3_4_38_2","doi-asserted-by":"publisher","DOI":"10.36106\/gjra\/3602003"},{"key":"e_1_3_4_39_2","doi-asserted-by":"publisher","DOI":"10.25048\/tudod.1041387"},{"key":"e_1_3_4_40_2","doi-asserted-by":"publisher","DOI":"10.1515\/jomb-2017-0020"},{"key":"e_1_3_4_41_2","doi-asserted-by":"publisher","DOI":"10.2478\/jomb-2018-0008"},{"key":"e_1_3_4_42_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-020-01430-2"},{"key":"e_1_3_4_43_2","article-title":"Body composition in lean women with polycystic ovary syndrome (PCOS) in relation to lipids and insulin resistance","volume":"41","author":"Bogavac T","year":"2016","unstructured":"Bogavac T, Bozic-Antic I, Ilic D, et al. Body composition in lean women with polycystic ovary syndrome (PCOS) in relation to lipids and insulin resistance. Female Reproductive 2016; 41: EP689.","journal-title":"Female Reproductive"},{"key":"e_1_3_4_44_2","doi-asserted-by":"publisher","DOI":"10.3390\/cells12060855"},{"key":"e_1_3_4_45_2","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.114.304136"},{"key":"e_1_3_4_46_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2011.04.044"},{"key":"e_1_3_4_47_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.rbmo.2022.11.013"},{"key":"e_1_3_4_48_2","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/812610"},{"key":"e_1_3_4_49_2","doi-asserted-by":"publisher","DOI":"10.3349\/ymj.2016.57.6.1404"},{"key":"e_1_3_4_50_2","article-title":"Exploring adipsin, irisin, and osteopontin as biomarkers in polycystic ovary syndrome and their associations with metabolic alterations: a prospective, case-control study","author":"Duzenli F","year":"2023","unstructured":"Duzenli F, Yurtcu E, Keyif B, et al. Exploring adipsin, irisin, and osteopontin as biomarkers in polycystic ovary syndrome and their associations with metabolic alterations: a prospective, case-control study. Res Square 2023.","journal-title":"Res Square"},{"key":"e_1_3_4_51_2","first-page":"261","article-title":"Cardiometabolic risk factors and its association with hyperandrogenemia among sudanese reproductive women with polycystic ovary syndrome","volume":"13","author":"Elmugadam A","year":"2023","unstructured":"Elmugadam A, Alhassan SM, Ghada AE, et al. Cardiometabolic risk factors and its association with hyperandrogenemia among sudanese reproductive women with polycystic ovary syndrome. Int J Biomed 2023; 13: 261\u2013268.","journal-title":"Int J Biomed"},{"key":"e_1_3_4_52_2","first-page":"29","article-title":"Correlation of serum lipoprotein ratios with insulin resistance in infertile women with polycystic ovarian syndrome: a case control study","volume":"10","author":"Ghaffarzad A","year":"2016","unstructured":"Ghaffarzad A, Amani R, Mehrzad Sadaghiani M, et al. Correlation of serum lipoprotein ratios with insulin resistance in infertile women with polycystic ovarian syndrome: a case control study. Int J Fertil Steril 2016; 10: 29\u201335.","journal-title":"Int J Fertil Steril"},{"key":"e_1_3_4_53_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40519-020-00980-x"},{"key":"e_1_3_4_54_2","doi-asserted-by":"crossref","first-page":"65","DOI":"10.51481\/amc.v65i2.1265","article-title":"Caracterizaci\u00f3n de mujeres universitarias con s\u00edndrome de ovario poliqu\u00edstico en Costa Rica","volume":"65","author":"Gonz\u00e1lez-Salazar M","year":"2023","unstructured":"Gonz\u00e1lez-Salazar M, Chinchilla-Monge R, Holst-Schumacher I, et al. Caracterizaci\u00f3n de mujeres universitarias con s\u00edndrome de ovario poliqu\u00edstico en Costa Rica. Acta M\u00e9d Costarric 2023; 65: 65\u201376.","journal-title":"Acta M\u00e9d Costarric"},{"key":"e_1_3_4_55_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12011-014-9941-7"},{"key":"e_1_3_4_56_2","doi-asserted-by":"publisher","DOI":"10.1590\/1806-9282.20220854"},{"key":"e_1_3_4_57_2","unstructured":"Haddad S. Correlation between insulin resistance and serum lipoprotein ratios in polycystic ovary syndrome patients. Syrian Clin Lab Assoc 2014; 7."},{"key":"e_1_3_4_58_2","doi-asserted-by":"publisher","DOI":"10.15296\/ijwhr.2021.05"},{"key":"e_1_3_4_59_2","first-page":"29","article-title":"Increased TG\/HDL ratio, a surrogate marker of insulin resistance in PCOS women","volume":"16","author":"Hariprasath G","year":"2017","unstructured":"Hariprasath G, Sakila S, LavanyaKumari K, et al. Increased TG\/HDL ratio, a surrogate marker of insulin resistance in PCOS women. J Dent Med Sci 2017; 16: 29\u201332.","journal-title":"J Dent Med Sci"},{"key":"e_1_3_4_60_2","article-title":"Lipid profile in Sudanese patients with polycystic ovary syndrome","volume":"2","author":"Hassan SM","year":"2015","unstructured":"Hassan SM, Modawe GA, Abdrabo AA. Lipid profile in Sudanese patients with polycystic ovary syndrome. Br J Med Med Res 2015; 2.","journal-title":"Br J Med Med Res"},{"key":"e_1_3_4_61_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jri.2016.06.002"},{"key":"e_1_3_4_62_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0232299"},{"key":"e_1_3_4_63_2","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.799833"},{"key":"e_1_3_4_64_2","doi-asserted-by":"publisher","DOI":"10.1177\/20420188211066699"},{"key":"e_1_3_4_65_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jogc.2018.11.026"},{"key":"e_1_3_4_66_2","first-page":"30","article-title":"Association of hormonal status with anthropometric & biochemical parameters in women with polycystic ovarian syndrome","volume":"4","author":"Kumar Shah A","year":"2017","unstructured":"Kumar Shah A, Sarin M, Karunanand B, et al. Association of hormonal status with anthropometric & biochemical parameters in women with polycystic ovarian syndrome. J Community Health 2017; 4: 30\u201334.","journal-title":"J Community Health"},{"key":"e_1_3_4_67_2","doi-asserted-by":"publisher","DOI":"10.18311\/jer\/2023\/33508"},{"key":"e_1_3_4_68_2","article-title":"Study of lipid profile and high sensitivity C reactive protein in women with polycystic ovary syndrome","volume":"3","author":"Lath R","year":"2017","unstructured":"Lath R, Jibhkate A, Shendye R. Study of lipid profile and high sensitivity C reactive protein in women with polycystic ovary syndrome. Int Arch BioMed Clin Res 2017; 3: 80\u201383.","journal-title":"Int Arch BioMed Clin Res"},{"key":"e_1_3_4_69_2","doi-asserted-by":"publisher","DOI":"10.26452\/ijrps.v11i4.3855"},{"key":"e_1_3_4_70_2","doi-asserted-by":"publisher","DOI":"10.1080\/09513590.2018.1505843"},{"key":"e_1_3_4_71_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2003-032049"},{"key":"e_1_3_4_72_2","doi-asserted-by":"publisher","DOI":"10.1007\/s13224-016-0898-7"},{"key":"e_1_3_4_73_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2015.12.024"},{"key":"e_1_3_4_74_2","first-page":"4","article-title":"Avalia\u00e7\u00e3o bioqu\u00edmica entre obesas portadoras e n\u00e3o-portadoras da s\u00edndrome dos ov\u00e1rios polic\u00edsticos","volume":"9","author":"Queiroz R","year":"2020","unstructured":"Queiroz R, Lins T. Avalia\u00e7\u00e3o bioqu\u00edmica entre obesas portadoras e n\u00e3o-portadoras da s\u00edndrome dos ov\u00e1rios polic\u00edsticos. REVISA 2020; 9: 4\u201312.","journal-title":"REVISA"},{"key":"e_1_3_4_75_2","doi-asserted-by":"publisher","DOI":"10.5455\/2319-2003.ijbcp20140224"},{"key":"e_1_3_4_76_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1575-0922(09)70553-4"},{"key":"e_1_3_4_77_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1447-0756.2010.01375.x"},{"key":"e_1_3_4_78_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2007.01.032"},{"key":"e_1_3_4_79_2","doi-asserted-by":"publisher","DOI":"10.15380\/2277-5706.JCSR.14.007"},{"key":"e_1_3_4_80_2","doi-asserted-by":"publisher","DOI":"10.14260\/jemds\/2019\/292"},{"key":"e_1_3_4_81_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2013.05.003"},{"key":"e_1_3_4_82_2","doi-asserted-by":"publisher","DOI":"10.3109\/09513590.2010.551566"},{"key":"e_1_3_4_83_2","doi-asserted-by":"publisher","DOI":"10.18621\/eurj.1064555"},{"key":"e_1_3_4_84_2","first-page":"64","article-title":"Evaluation of homocysteine, C-reactive protein and lipid profile as markers of cardiovascular risk in women with polycystic ovarian syndrome [PCOS]","volume":"8","author":"Vanaja PR","year":"2019","unstructured":"Vanaja PR, Mohanty S. Evaluation of homocysteine, C-reactive protein and lipid profile as markers of cardiovascular risk in women with polycystic ovarian syndrome [PCOS]. Glob J Res Anal 2019; 8: 64\u201366.","journal-title":"Glob J Res Anal"},{"key":"e_1_3_4_85_2","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-61-5-946"},{"key":"e_1_3_4_86_2","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/173281"},{"key":"e_1_3_4_87_2","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000005524"},{"key":"e_1_3_4_88_2","doi-asserted-by":"publisher","DOI":"10.1080\/09513590.2023.2172154"},{"key":"e_1_3_4_89_2","doi-asserted-by":"publisher","DOI":"10.1515\/tjb-2023-0215"},{"key":"e_1_3_4_90_2","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/des191"},{"key":"e_1_3_4_91_2","doi-asserted-by":"publisher","DOI":"10.2147\/IJWH.S387942"},{"key":"e_1_3_4_92_2","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/deh098"},{"key":"e_1_3_4_93_2","first-page":"377","volume-title":"Polycystic ovary syndrome","author":"Zawadski JK","year":"1992","unstructured":"Zawadski JK, Dunaif A. Diagnostic criteria for polycystic ovary syndrome: towards a rational approach. In: Dunaif A, Givens JR, Haseltine F (eds) Polycystic ovary syndrome. Boston: Blackwell Scientific, 1992, pp. 377\u2013384."},{"key":"e_1_3_4_94_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2008.06.035"},{"key":"e_1_3_4_95_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40292-023-00585-2"},{"key":"e_1_3_4_96_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-022-01546-0"},{"key":"e_1_3_4_97_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-021-01268-9"},{"key":"e_1_3_4_98_2","first-page":"53","article-title":"Triglyceride to high-density lipoprotein cholesterol and low-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratios are predictors of cardiovascular risk in Iranian adults: evidence from a population-based cross-sectional study","volume":"11","author":"Hajian-Tilaki K","year":"2020","unstructured":"Hajian-Tilaki K, Heidari B, Bakhtiari A. Triglyceride to high-density lipoprotein cholesterol and low-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratios are predictors of cardiovascular risk in Iranian adults: evidence from a population-based cross-sectional study. Caspian J Intern Med 2020; 11: 53\u201361.","journal-title":"Caspian J Intern Med"},{"key":"e_1_3_4_99_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.161.22.2685"},{"key":"e_1_3_4_100_2","doi-asserted-by":"publisher","DOI":"10.1038\/oby.2009.446"},{"key":"e_1_3_4_101_2","doi-asserted-by":"publisher","DOI":"10.1007\/s42000-023-00438-6"},{"key":"e_1_3_4_102_2","doi-asserted-by":"publisher","DOI":"10.15272\/ajbps.v5i47.726"},{"key":"e_1_3_4_103_2","article-title":"Association between lipid ratios and insulin resistance in a Chinese population","volume":"10","author":"Zhang L","year":"2015","unstructured":"Zhang L, Chen S, Deng A, et al. Association between lipid ratios and insulin resistance in a Chinese population. PLoS One 2015; 10: e0116110.","journal-title":"PLoS One"},{"key":"e_1_3_4_104_2","doi-asserted-by":"publisher","DOI":"10.5551\/jat.RV17023"},{"key":"e_1_3_4_105_2","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.892125"},{"key":"e_1_3_4_106_2","first-page":"569","article-title":"The importance of lipid spectrum changes in women with polycystic ovary syndrome (PCOS)","volume":"115","author":"Sarapatkova H","year":"2014","unstructured":"Sarapatkova H, Sarapatka J, Frysak Z. The importance of lipid spectrum changes in women with polycystic ovary syndrome (PCOS). Bratisl Lek Listy 2014; 115: 569\u2013572.","journal-title":"Bratisl Lek Listy"},{"key":"e_1_3_4_107_2","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2024.1373039"},{"key":"e_1_3_4_108_2","doi-asserted-by":"publisher","DOI":"10.1080\/09513590.2023.2216807"},{"key":"e_1_3_4_109_2","doi-asserted-by":"publisher","DOI":"10.3109\/09513590.2015.1075501"},{"key":"e_1_3_4_110_2","doi-asserted-by":"publisher","DOI":"10.1515\/med-2022-0590"},{"key":"e_1_3_4_111_2","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.123.033572"},{"key":"e_1_3_4_112_2","doi-asserted-by":"publisher","DOI":"10.1111\/obr.12762"},{"key":"e_1_3_4_113_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmjebm-2022-112053"},{"key":"e_1_3_4_114_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-14-25"}],"container-title":["Therapeutic Advances in Endocrinology and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/20420188251328840","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/20420188251328840","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/20420188251328840","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T23:36:49Z","timestamp":1777592209000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/20420188251328840"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,31]]},"references-count":113,"alternative-id":["10.1177\/20420188251328840"],"URL":"https:\/\/doi.org\/10.1177\/20420188251328840","relation":{},"ISSN":["2042-0188","2042-0196"],"issn-type":[{"value":"2042-0188","type":"print"},{"value":"2042-0196","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,31]]},"article-number":"20420188251328840"}}